India's weight-loss drug boom raises questions over healthcare priorities

A rapid increase in demand for weight‑loss medicines is reshaping India's pharmaceutical market. Sales of these drugs have surged, creating a noticeable boom in the sector. Health officials note that the growth comes amid broader public health challenges. Critics argue that resources may be diverted from essential healthcare services. The debate highlights tensions between consumer demand and national health priorities. Policymakers are being urged to balance commercial success with equitable care. Observers suggest that regulatory scrutiny could increase as the market expands. The outcome may influence future funding allocations for Indian health programs.